Sweet Syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female, SEPT 2021.
"The patient (female, 65 years) had received her first dose of COVID 19 vaccine (Oxford-AstraZeneca COVID-19 vaccine-Covishield) about 7-days before the onset of the rash. After the vaccination, the patient had developed fever on the second day followed by the rash after about 7-days. The rash had started acutely on the hands and progressed rapidly over 1-2 days to involve her feet as well. The patient was finding it difficult to walk properly because of the lesions on her feet. The rash was associated with fever of mild to moderate degree and there was history of joint pains involving the hand and feet joints as well." onlinelibrary.wiley.com/doi...